Novel and potent tacrine-related hetero- and homobivalent ligands for acetylcholinesterase and butyrylcholinesterase.

Based upon synthetic and biochemical results, a novel and potent tacrine analogue and heterobivalent analogues of tacrine, were designed. The role played by the amino groups of homo- and heterobivalent ligands in the interaction with the peripheral and catalytic sites of AChE and BuChE were investigated. The syntheses of these materials together with the results of AChE/BuChE inhibition assays are detailed.

[1]  D. Mash,et al.  Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. , 1989, The Journal of pharmacology and experimental therapeutics.

[2]  Xuliang Jiang,et al.  Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. , 1997 .

[3]  A. Cavalli,et al.  SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues. , 2000, Journal of medicinal chemistry.

[4]  S. Brimijoin,et al.  Highly Potent, Selective, and Low Cost Bis-tetrahydroaminacrine Inhibitors of Acetylcholinesterase , 1996, The Journal of Biological Chemistry.

[5]  J. Seravalli,et al.  Molecular recognition in acetylcholinesterase catalysis: free-energy correlations for substrate turnover and inhibition by trifluoro ketone transition-state analogs. , 1994, Biochemistry.

[6]  C. Lipinski,et al.  Physical parameters for brian uptake: optimizing log P, log D and pKa of T H A , 1991 .

[7]  J. Massoulie.  Cholinesterases : structure, function, mechanism, genetics, and cell biology , 1991 .

[8]  C. J. Moore,et al.  The synthesis and in vitro acetylcholinesterase and butyrylcholinesterase inhibitory activity of tacrine (Cognex®) derivaties , 1992 .

[9]  P. Carlier,et al.  Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions. , 1999, Journal of medicinal chemistry.

[10]  P. Carlier,et al.  Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis. , 1999, Bioorganic & medicinal chemistry.